[go: up one dir, main page]

BR0011441A - Derivados de rodanina para uso em um método de inibição da agregação da proteìna amilóide e formação de imagens de depósitos amilóides - Google Patents

Derivados de rodanina para uso em um método de inibição da agregação da proteìna amilóide e formação de imagens de depósitos amilóides

Info

Publication number
BR0011441A
BR0011441A BR0011441-3A BR0011441A BR0011441A BR 0011441 A BR0011441 A BR 0011441A BR 0011441 A BR0011441 A BR 0011441A BR 0011441 A BR0011441 A BR 0011441A
Authority
BR
Brazil
Prior art keywords
imaging
amyloid
inhibiting
protein aggregation
deposits
Prior art date
Application number
BR0011441-3A
Other languages
English (en)
Inventor
Corinne Elizab Augelli-Szafran
Shelly Ann Glasse
Lary Craswell Walker
Tomoyuki Yasunaga
Original Assignee
Warner Lambert Co
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co, Yamanouchi Pharma Co Ltd filed Critical Warner Lambert Co
Publication of BR0011441A publication Critical patent/BR0011441A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"DERIVADOS DE RODANINA PARA USO EM UM MéTODO DE INIBIçãO DA AGREGAçãO DA PROTEìNA AMILóIDE E FORMAçãO DE IMAGENS DE DEPóSITOS AMILóIDES". A presente invenção proporcionar um método de tratamento de mal de Alzheimer usando-se um composto da Fórmula (I). Também proporcionado é um método de inibição da agregação de proteínas amilóides usando-se um composto da Fórmula (I) e um método de formação de imagens de depósitos amilóides usando-se os compostos da Fórmula (I).
BR0011441-3A 1999-06-10 2000-05-31 Derivados de rodanina para uso em um método de inibição da agregação da proteìna amilóide e formação de imagens de depósitos amilóides BR0011441A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13854499P 1999-06-10 1999-06-10
PCT/US2000/015069 WO2000076987A1 (en) 1999-06-10 2000-05-31 Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits

Publications (1)

Publication Number Publication Date
BR0011441A true BR0011441A (pt) 2002-07-16

Family

ID=22482512

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011441-3A BR0011441A (pt) 1999-06-10 2000-05-31 Derivados de rodanina para uso em um método de inibição da agregação da proteìna amilóide e formação de imagens de depósitos amilóides

Country Status (8)

Country Link
EP (1) EP1192143A1 (pt)
JP (1) JP2003502320A (pt)
AU (1) AU5311800A (pt)
BR (1) BR0011441A (pt)
CA (1) CA2374616A1 (pt)
MX (1) MXPA01010490A (pt)
TR (1) TR200103562T2 (pt)
WO (1) WO2000076987A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
AU2003280188A1 (en) 2002-12-06 2004-06-30 Warner-Lambert Company Llc Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
US20060106077A1 (en) * 2003-07-18 2006-05-18 Pintex Pharmaceuticals, Inc. Pin1-Modulating compounds and methods of use thereof
CA2676715A1 (en) 2007-02-12 2008-08-21 Merck & Co., Inc. Piperazine derivatives for treatment of ad and related conditions
CN103402516B (zh) 2010-06-17 2018-01-30 富津世生物技术有限公司 用作抗病毒药物的化合物、组合物及使用方法
CN106045986B (zh) * 2016-05-31 2019-12-06 广东工业大学 一种新型吩噻嗪衍生物及其制备方法与应用
CN106045987B (zh) * 2016-06-21 2019-04-23 广东工业大学 一种具有多功能近红外荧光磁性纳米微粒及其制备和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
JPH01147462A (ja) * 1987-12-03 1989-06-09 Mita Ind Co Ltd 電荷発生材料およびその製法
JPH01147476A (ja) * 1987-12-03 1989-06-09 Mita Ind Co Ltd 光導電性トナー
US5143929A (en) * 1991-05-09 1992-09-01 Warner-Lambert Company 2-substituted thiazolidinone, oxazolidinone, and imidazolidinone derivatives of fenamates as antiinflammatory agents
IL106877A (en) * 1992-09-10 1998-03-10 Lilly Co Eli Rhodanine derivatives for use as medicaments for the treatment of alzheimer's disease
DE4318550A1 (de) * 1993-06-04 1994-12-08 Boehringer Mannheim Gmbh Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US6251928B1 (en) * 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US6001331A (en) * 1996-01-24 1999-12-14 Warner-Lambert Company Method of imaging amyloid deposits
CN1325309A (zh) * 1998-08-21 2001-12-05 维洛药品公司 用于治疗或预防病毒感染和相关疾病的化合物、组合物和方法
AU6330799A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders

Also Published As

Publication number Publication date
WO2000076987A1 (en) 2000-12-21
MXPA01010490A (es) 2005-05-27
AU5311800A (en) 2001-01-02
CA2374616A1 (en) 2000-12-21
EP1192143A1 (en) 2002-04-03
JP2003502320A (ja) 2003-01-21
TR200103562T2 (tr) 2002-04-22

Similar Documents

Publication Publication Date Title
TR200200257T2 (tr) Amiloid protein birikimi inhibisyonu ve izoindolin türevleri kullanılarak amidoid tortularının görüntülenmesi yöntemi.
PT907379E (pt) Agentes de contraste bioactivados para imagiologia de diagnostico
BR9408407A (pt) Uso de inibidores pla2 como tratamento para doença de alzheimer
BR9912943A (pt) Peptìdeos inibidores de hepatite c
CY1110448T1 (el) Ενωσεις ριλουζολης και λεβαντοπας για τη θεραπεια της ασθενειας του παρκινσον
ATE185797T1 (de) Stilben-derivate verwendbar als cyclooxygenase-2 hemmer
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
UY26813A1 (es) Compuestos para tratar enfermedad de alzheimer
BR9609503A (pt) Composto, uso de um composto, processo de tratamento de condições onde a inibição de pde especìfico para cgmp é de benefìcio terapêutico, em corpo de animal humano ou não humano, composição farmacêutica, e processos para preparar a mesma e um composto
IT1269826B (it) Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate
BR0010520A (pt) Novos compostos farmaceuticamente ativos
BR9910035A (pt) Derivados de guanidina
BR0112674A (pt) Inibidores n-[5-[[[5-alquil-2-oxazolil]metil] tio]-2tiazolil]carboxamida de quinases dependentes de ciclina
NO975758D0 (no) Heterosykliske frie metylradikaler som bildeforbedrende milder
CY1107116T1 (el) Νεες κυκλοεξυλ σουλφονες
GEP20053423B (en) Method of Inhibiting Amyloid Protein Aggregation and Method for Imaging of Amyloid Deposits
NO20002517D0 (no) Magnetisk resonansavbildningsmidler for deteksjon av fysiologiske midler
ES2122637T3 (es) Derivados de tiazolidina, su preparacion y los medicamentos que les contienen.
NO20020176D0 (no) Sykliske peptidderivater som inhibitorer for intergrin <alfa>v<beta>6
DE3851232D1 (de) Substituierte chinoline.
BR0113590A (pt) 7-oxo-piridopirimidinas
BR0011441A (pt) Derivados de rodanina para uso em um método de inibição da agregação da proteìna amilóide e formação de imagens de depósitos amilóides
BR0110519A (pt) Método para inibir a agregação de proteìnas amilóides e formar imagens dos depósitos de amilóides usando derivados de aminoindano
NO20002115L (no) Magnetiske resonansavbildingsmidler for avlevering av terapeutiske midler

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 8O E 9O ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.